Remove tag drug-importation
article thumbnail

What is Biogen and can they repair their reputation?

World of DTC Marketing

This drug was never about patients; it was about a company whose ego got too big and needed a savior in the form of a medicine that could bring in hundreds of millions of dollars. They had a new MS drug that was the talk of the industry and an exciting pipeline. Biogen is in trouble. He has zero credibility with the HCP community.

Insurance 222
article thumbnail

BD partners with Biocorp on connected self-injection devices

pharmaphorum

Medtech giant Beckton Dickinson (BD) has signed a deal with France’s Biocorp to use the latter’s near-field communication (NFC) tags in injectable devices. The Injay tag can confirm a complete injection and transfer that information via an NFC reader to a smartphone or tablet for review by a healthcare professional.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Orphan drugs and where to launch them: The keys to Europe’s forgotten territories

Pharmaceutical Technology

The commercial investment required to research and develop an innovative drug, prove its safety and efficacy, and bring it to market is staggering. Most famously, the US passed its Orphan Drug Act in 1983, providing innovators with financial motivation to develop orphan drugs and meet the needs of these forgotten patients.

article thumbnail

After a slow start for expensive CAR-T therapies, drug developers revisit oral therapies for blood cancer

pharmaphorum

There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives. These are particularly important in the progression of certain blood cancers.

article thumbnail

Pioneering the Path Pre- and Post-Launch Strategies

PM360

Driving an Integrated Evidence Strategy Evidence-based decision-making and differentiation are of paramount importance for HCPs who are flooded with therapy options or are circumspect to adopt a new therapy. Data as the Accelerator for Medical Affairs’ Role Evolution At the heart of the transformation of Medical Affairs is the power of data.

Medical 52
article thumbnail

How automation can help to address supply chain challenges in pharma

pharmaphorum

Incidents such as the hormone replacement therapy drug shortage in early 2022 have shown the damaging impact supply chain issues can have on people who depend on these drugs. Mix ups in hand-offs are another large disruptor, especially when drugs have specific shipping requirements. Automation can be such a solution.

Pharma 100
article thumbnail

What Role Does Healthcare SEO Play in a 2023 Marketing Strategy?

LEVO Health

This can include optimizing the website’s content, meta tags, and images for search engines. New treatments, drugs, and technologies are constantly being developed. Once they land on your site, it’s important to make sure the user experience is optimized and your healthcare website is accessible.